Form 4: Chemed Corp CEO Kevin McNamara Reports Stock Transactions
SEC Form 4 Filing
Chemed Corp's CEO, Kevin McNamara, reports exercising stock options and selling shares on August 5, 2024.
Summary
- On August 5, 2024, Kevin J. McNamara, the President and CEO of Chemed Corp, executed several transactions involving Chemed Corp capital stock.
- McNamara exercised stock options to acquire 5,000 shares at a price of $445.35 per share.
- He then sold 2,000 shares at a weighted average price of $569.63, with prices ranging from $565.63 to $579.09.
- Additionally, 4,314 shares were disposed of to cover the purchase price and tax obligations related to the stock option exercise at $586.14.
- Following these transactions, McNamara directly owns 105,735 shares of Chemed Corp capital stock and holds options for 177,155 shares.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, with neutral sentiment.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the actions of company executives.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the overall impact is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 10/28/2022 | Commencement date for vesting of stock options in three equal annual installments. |
| 08/05/2024 | Date of stock option exercise and stock sales. |
| 08/06/2024 | Date of signature on the Form 4 filing. |
| 10/28/2026 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.